Alaffia Health Snags $55M for AI Engine Tackling Healthcare’s Waste Problem Leave a comment
Providers’ rapid adoption of AI is pushing payers to accelerate their own use of administrative AI tools, with health plans looking for ways to keep pace and manage the growing complexity of claims review.
On Tuesday, a New York-based startup providing technology that promises to do just that announced the close of a $55 million Series B funding round led by Transformation Capital. The company, called Alaffia Health, has raised a total of $73 million since its founding in 2020. Some of its other investors include FirstMark Capital, Tau Ventures and Twine Ventures.
Alaffia exists to help health plans reduce waste by making claims review faster and easier to defend, said CEO TJ Ademiluyi.
Many claims are still reviewed manually and inconsistently, often without full clinical context — a dynamic that can lead to overpayments, slow turnaround times, strained provider relationships and greater regulatory risk, he explained.
“At a high level, Alaffia pairs experienced clinicians with agentic AI that understands the full breadth of claims and their supporting clinical information, including the patient medical record — data that is often unstructured, siloed and overlooked,” Ademiluyi stated.
The platform extracts key clinical facts from medical records and other documentation, then it compares those facts against what the provider billed to determine whether a claim is accurate and aligned with health plan reimbursement policies and clinical guidelines.
Ademiluyi said that the AI “handles the heavy lifting” by synthesizing complex data and surfacing clear findings, allowing health plan teams to quickly understand how a claim was billed and why.
“Clinicians remain at the helm, reviewing the AI’s outputs and making the final determination,” he added.
He described Alaffia’s target customers as regional and national health plans and said that the company competes with legacy payment integrity vendors and newer AI-only healthcare automation tools.
Ademiluyi pointed out that legacy vendors typically rely heavily on manual processes, while AI-only tools may move quickly but struggle with explainability, configurability and regulatory trust.
He said Alaffia differentiates itself through its transparency and clinical oversight. He also noted that the platform is purpose-built for real-world payer environments and designed with ever-changing compliance guidelines in mind.
“This balance allows Alaffia to deliver meaningful savings without increasing compliance or provider-relations risk,” Ademiluyi declared.
Whether that approach becomes the model for administrative AI adoption across health plans remains to be seen, but investor interest suggests the bet is gaining traction.
Photo: Richard Drury, Getty Images
